Skip to main content
. 2022 May 12;10(3):e00797-22. doi: 10.1128/spectrum.00797-22

TABLE 3.

Performance of Spike SNP assays in salivaa

Assay Screening assay result Whole genome sequencing result
Assay clinical analysis
Reference Substitution Alternate % Accuracy % Clinical sensitivity % Clinical specificity % PPV % NPV
K417T Reference 176 0 0 99.20 [98.10, 100.0a] 97.30 [93.55, 100.0] 100.0 [100.0] 100.0 [100.0] 98.88 [97.33, 100.0]
Substitution 0 64 0
Inconclusive 2 0 8
E484K Reference 173 0 0 96.40 [94.09, 98.71] 88.31 [80.67, 95.95] 100.0 [100.0] 100.0 [100.0] 95.05 [91.90, 98.20]
Substitution 0 68 0
Inconclusive 2 7 0
E484Q Reference 179 0 0 99.60 [98.88, 100.0] 98.59 [95.83, 100.0] 100.0 [100.0] 100.0 [100.0] 99.44 [98.35, 100.0]
Substitution 0 0 0
Inconclusive 1 0 70
L452R Reference 181 2 0 96.80 [94.62, 98.98] 88.41 [80.38, 96.47] 100.0 [100.0] 100.0 [100.0] 95.77 [92.90, 98.64]
Substitution 0 61 0
Inconclusive 4 2 0
a

Upper-bound value cannot exceed 100.0%. This applies to all measurements. 95% confidence interval is represented in brackets.